Growth Metrics

Immucell (ICCC) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to -$592024.0.

  • Immucell's Cash from Investing Activities fell 56961.95% to -$592024.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 43766.32%. This contributed to the annual value of -$461225.0 for FY2024, which is 7559.71% up from last year.
  • Per Immucell's latest filing, its Cash from Investing Activities stood at -$592024.0 for Q3 2025, which was down 56961.95% from -$125927.0 recorded in Q2 2025.
  • Immucell's 5-year Cash from Investing Activities high stood at $656684.0 for Q1 2021, and its period low was -$1.5 million during Q4 2022.
  • For the 5-year period, Immucell's Cash from Investing Activities averaged around -$471573.6, with its median value being -$592024.0 (2025).
  • Per our database at Business Quant, Immucell's Cash from Investing Activities surged by 10226.7% in 2023 and then plummeted by 68081.28% in 2024.
  • Quarter analysis of 5 years shows Immucell's Cash from Investing Activities stood at -$703279.0 in 2021, then plummeted by 111.89% to -$1.5 million in 2022, then skyrocketed by 102.27% to $33783.0 in 2023, then tumbled by 680.81% to -$196216.0 in 2024, then plummeted by 201.72% to -$592024.0 in 2025.
  • Its Cash from Investing Activities was -$592024.0 in Q3 2025, compared to -$125927.0 in Q2 2025 and -$329050.0 in Q1 2025.